D C Henstridge1, C R Bruce1,2, C P Pang1, G I Lancaster1, T L Allen1, E Estevez1, T Gardner1, J M Weir3, P J Meikle3, K S L Lam4, A Xu4, N Fujii5, L J Goodyear6, M A Febbraio7. 1. Cellular and Molecular Metabolism Laboratory, Baker IDI Heart and Diabetes Institute, 75 Commercial Rd, Melbourne, VIC, 3004, Australia. 2. Department of Physiology, Monash University, Clayton, VIC, Australia. 3. Metabolomics Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia. 4. Department of Medicine and Research Center for Heart, Brain, Hormones, and Healthy Aging, University of Hong Kong, Hong Kong, SAR, People's Republic of China. 5. Department of Health Promotion Science, Tokyo Metropolitan University, Hachioji, Tokyo, Japan. 6. Joslin Diabetes Center, Boston, MA, USA. 7. Cellular and Molecular Metabolism Laboratory, Baker IDI Heart and Diabetes Institute, 75 Commercial Rd, Melbourne, VIC, 3004, Australia. mark.febbraio@bakeridi.edu.au.
Abstract
AIMS/HYPOTHESIS: Although skeletal muscle insulin resistance has been associated with activation of c-Jun N-terminal kinase (JNK), whether increased JNK activity causes insulin resistance in this organ is not clear. In this study we examined the metabolic consequences of isolated JNK phosphorylation in muscle tissue. METHODS: Plasmids containing genes encoding a wild-type JNK1 (WT-JNK) or a JNK1/JNKK2 fusion protein (rendering JNK constitutively active; CA-Jnk) were electroporated into one tibialis anterior (TA) muscle of C57Bl/6 mice, with the contralateral TA injected with an empty vector (CON) to serve as a within-animal control. RESULTS: Overproduction of WT-JNK resulted in a modest (~25%) increase in phosphorylation (Thr(183)/Tyr(185)) of JNK, but no differences were observed in Ser(307) phosphorylation of insulin receptor substrate 1 (IRS-1) or total IRS-1 protein, nor in insulin-stimulated glucose clearance into the TA muscle when comparing WT-JNK with CON. By contrast, overexpression of CA-Jnk, which markedly increased the phosphorylation of CA-JNK, also increased serine phosphorylation of IRS-1, markedly decreased total IRS-1 protein, and decreased insulin-stimulated phosphorylation of the insulin receptor (Tyr(1361)) and phosphorylation of Akt at (Ser(473) and Thr(308)) compared with CON. Moreover, overexpression of CA-Jnk decreased insulin-stimulated glucose clearance into the TA muscle compared with CON and these effects were observed without changes in intramuscular lipid species. CONCLUSIONS/ INTERPRETATION: Constitutive activation of JNK in skeletal muscle impairs insulin signalling at the level of IRS-1 and Akt, a process which results in the disruption of normal glucose clearance into the muscle.
AIMS/HYPOTHESIS: Although skeletal muscle insulin resistance has been associated with activation of c-Jun N-terminal kinase (JNK), whether increased JNK activity causes insulin resistance in this organ is not clear. In this study we examined the metabolic consequences of isolated JNK phosphorylation in muscle tissue. METHODS: Plasmids containing genes encoding a wild-type JNK1 (WT-JNK) or a JNK1/JNKK2 fusion protein (rendering JNK constitutively active; CA-Jnk) were electroporated into one tibialis anterior (TA) muscle of C57Bl/6 mice, with the contralateral TA injected with an empty vector (CON) to serve as a within-animal control. RESULTS: Overproduction of WT-JNK resulted in a modest (~25%) increase in phosphorylation (Thr(183)/Tyr(185)) of JNK, but no differences were observed in Ser(307) phosphorylation of insulin receptor substrate 1 (IRS-1) or total IRS-1 protein, nor in insulin-stimulated glucose clearance into the TA muscle when comparing WT-JNK with CON. By contrast, overexpression of CA-Jnk, which markedly increased the phosphorylation of CA-JNK, also increased serine phosphorylation of IRS-1, markedly decreased total IRS-1 protein, and decreased insulin-stimulated phosphorylation of the insulin receptor (Tyr(1361)) and phosphorylation of Akt at (Ser(473) and Thr(308)) compared with CON. Moreover, overexpression of CA-Jnk decreased insulin-stimulated glucose clearance into the TA muscle compared with CON and these effects were observed without changes in intramuscular lipid species. CONCLUSIONS/ INTERPRETATION: Constitutive activation of JNK in skeletal muscle impairs insulin signalling at the level of IRS-1 and Akt, a process which results in the disruption of normal glucose clearance into the muscle.
Authors: Guadalupe Sabio; Madhumita Das; Alfonso Mora; Zhiyou Zhang; John Y Jun; Hwi Jin Ko; Tamera Barrett; Jason K Kim; Roger J Davis Journal: Science Date: 2008-12-05 Impact factor: 47.728
Authors: Nobuharu Fujii; Marni D Boppart; Scott D Dufresne; Patricia F Crowley; Alison C Jozsi; Kei Sakamoto; Haiyan Yu; Williams G Aschenbach; Shokei Kim; Hitoshi Miyazaki; Liangyou Rui; Morris F White; Michael F Hirshman; Laurie J Goodyear Journal: Am J Physiol Cell Physiol Date: 2004-03-10 Impact factor: 4.249
Authors: Darren C Henstridge; E Estevez; T L Allen; S E Heywood; T Gardner; C Yang; N A Mellett; B A Kingwell; P J Meikle; M A Febbraio Journal: Cell Stress Chaperones Date: 2015-01-25 Impact factor: 3.667
Authors: Jacquelyn M Weir; Gerard Wong; Christopher K Barlow; Melissa A Greeve; Adam Kowalczyk; Laura Almasy; Anthony G Comuzzie; Michael C Mahaney; Jeremy B M Jowett; Jonathan Shaw; Joanne E Curran; John Blangero; Peter J Meikle Journal: J Lipid Res Date: 2013-07-18 Impact factor: 5.922
Authors: Birgitte Lindegaard; Vance B Matthews; Claus Brandt; Pernille Hojman; Tamara L Allen; Emma Estevez; Matthew J Watt; Clinton R Bruce; Ole H Mortensen; Susanne Syberg; Caroline Rudnicka; Julie Abildgaard; Henriette Pilegaard; Juan Hidalgo; Susanne Ditlevsen; Thomas J Alsted; Andreas N Madsen; Bente K Pedersen; Mark A Febbraio Journal: Diabetes Date: 2013-05-13 Impact factor: 9.461